Alto Neuroscience, Inc.
- ANRO
- NYSE
- Biotechnology
- Psychiatric Drugs (MDD/PTSD)
- Clinical-Stage Biotech
$21.94
Today −3.01%Quote Oct 16, 2026, 08:00 PM UTC
−29.18%over the last month
Max drawdown −29.9%From 1-month high −29.2%3 months −15.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$861.0M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$38.00
+73.2% from here
Floor
$21.30
2.9% below price
Where the price sits
9 analysts
Analyst range, low to high
$24.00$55.00
- Price $21.94
- Resistance $22.84
- Consensus $38.00
Analysts' average target sits about 73% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ANROPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
68